Government looks to reassure applicants after Commission advice that UK participants on some EU research projects may have to leave after Brexit

Chris Jones, a civil servant, will advise ministers on the UK’s future relationship with EU science programmes

Employees are lukewarm on new locations and a slow-down in work rate will mean less income. In the best case scenario Europe’s drugs regulator will take 2-3 years to get back to speed after leaving London.

The UK space mission NovaSAR has attracted Australia to take a ten per cent share in the project, which aims to launch a satellite to track forestry management and shipping lanes in early 2018.

Only 5 of 19 cities bidding to host the European Medicines Agency would attract enough current employees for operations to continue as normal. Moving to one of the 8 least popular cities risks permanent damage, the agency warns

The UK wants a close relationship with EU science after Brexit. But there is much work to do if the UK government is to succeed in forging a closer partnership with the EU than exists with any other non-EU member

Strategy report calls for funding to create new industries, increased collaboration between pharmaceutical companies and the National Health Service, and incentives to keep the UK attractive to world class scientists after it leaves the EU